Clinical Trials

Showing trials with last updates posted in 2022.

NCT02451553 | COMPLETED | PHASE1
41 participants

Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2022-06-07
Start Date:
2015-11-05
Completion:
2022-04-16
Conditions
  • Advanced Malignant Solid Neoplasm
  • Bile Duct Carcinoma
  • Recurrent Malignant Solid Neoplasm
  • Recurrent Pancreatic Carcinoma
  • Stage III Pancreatic Cancer AJCC v6 and v7
  • Stage IVA Pancreatic Cancer
  • Stage IVB Pancreatic Cancer
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT02357810 | COMPLETED | PHASE2
178 participants

Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas

Study Type:
INTERVENTIONAL
Last Updated:
2022-06-07
Start Date:
2015-03-21
Completion:
2018-04-27
Conditions
  • Adult Liposarcoma
  • Metastatic Liposarcoma
  • Metastatic Osteosarcoma
  • Recurrent Adult Soft Tissue Sarcoma
  • Recurrent Liposarcoma
  • Recurrent Osteosarcoma
  • Stage IV Adult Soft Tissue Sarcoma
Interventions
  • DRUG
  • OTHER
NCT01664182 | COMPLETED | PHASE2
41 participants

Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2022-06-07
Start Date:
2012-08-01
Completion:
2020-12-07
Conditions
  • Advanced Renal Cell Carcinoma
  • Advanced Sarcomatoid Renal Cell Carcinoma
  • Stage III Renal Cell Cancer AJCC v7
  • Stage IV Renal Cell Cancer AJCC v7
Interventions
  • BIOLOGICAL
  • DRUG
NCT05406271 | UNKNOWN | NA
100 participants

Hip Prosthesis Components Position

Study Type:
INTERVENTIONAL
Last Updated:
2022-06-06
Start Date:
2022-06-01
Completion:
2022-12-31
Conditions
  • Hip Arthrosis
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page